$0.01 EPS Expected for Cogentix Medical, Inc. (CGNT)

February 25, 2018 - By Vivian Currie

 $0.01 EPS Expected for Cogentix Medical, Inc. (CGNT)

Analysts expect Cogentix Medical, Inc. (NASDAQ:CGNT) to report $0.01 EPS on March, 8.They anticipate $0.15 EPS change or 107.14 % from last quarter’s $-0.14 EPS. CGNT’s profit would be $609,055 giving it 72.25 P/E if the $0.01 EPS is correct. The stock decreased 2.03% or $0.06 during the last trading session, reaching $2.89. About 58,608 shares traded. Cogentix Medical, Inc. (NASDAQ:CGNT) has risen 83.33% since February 25, 2017 and is uptrending. It has outperformed by 66.63% the S&P500.

Cogentix Medical, Inc. (NASDAQ:CGNT) Ratings Coverage

Among 4 analysts covering Cogentix Medical (NASDAQ:CGNT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cogentix Medical had 8 analyst reports since November 5, 2015 according to SRatingsIntel. JMP Securities initiated the stock with “Buy” rating in Friday, October 6 report. TH Capital upgraded Cogentix Medical, Inc. (NASDAQ:CGNT) rating on Thursday, November 5. TH Capital has “Buy” rating and $3 target. Roth Capital maintained the stock with “Buy” rating in Wednesday, November 8 report. The stock has “Neutral” rating by Roth Capital on Friday, May 6. The stock of Cogentix Medical, Inc. (NASDAQ:CGNT) has “Buy” rating given on Thursday, November 5 by Roth Capital. The firm earned “Buy” rating on Wednesday, August 2 by Roth Capital. The company was maintained on Tuesday, July 18 by Roth Capital.

Cogentix Medical, Inc., a medical device company, designs, develops, makes, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide. The company has market cap of $176.02 million. The firm offers endoscopes, such as cystoscopes, laryngoscopes, transnasal esophagoscopes, and bronchoscopes for medical use; and borescopes for industrial use, as well as digital processing units for medical use. It currently has negative earnings. It also provides EndoSheath Protective Barrier, a sterile, single-use microbial barrier for use with flexible endoscopes.

More notable recent Cogentix Medical, Inc. (NASDAQ:CGNT) news were published by: Prnewswire.com which released: “Cogentix Medical Acquires Genesis Medical; Transaction to Further Increase …” on July 26, 2017, also Seekingalpha.com with their article: “A Technical Analysis Of Cogentix Medical: Poised To Break Out” published on December 06, 2017, Prnewswire.com published: “Cogentix Medical Enters Into Definitive Agreement For $25 Million Equity …” on September 07, 2016. More interesting news about Cogentix Medical, Inc. (NASDAQ:CGNT) were released by: Zacks.com and their article: “Cogentix Medical (CGNT) in Focus: Stock Moves 6.6% Higher December 04, 2017” published on December 04, 2017 as well as Prnewswire.com‘s news article titled: “Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US …” with publication date: July 18, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.